All filters
Videos
Session 7 Discussion
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
Improving PI drug resistance scores | Jens Verheyen, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
PI remain important options for first line | Linos Vandekerckhove, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
Session 5 Discussion
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
Maintenance Therapy - What is the scientific/ virological rational | Charles Boucher, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
HIV attachment Inhibitors - Educational lecture in collaboration with ESAR | Thomas Klimkait, MD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
Session 4 Discussion
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
Community perspective | Rebekah Webb
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
Roadblocks to implementation | Pep Coll, MD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
HIV in Europe 2020 – what will it look like? | Carlo Federico Perno, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
Regulatory landscape for NASH | Veronica Miller
Presented at:
HEP DART 2017
Videos
Update on Merck’s HCV Program | Mike Robertson
Presented at:
HEP DART 2017